A Novel Medical Device that Relieves Anxiety, Depression and Pain While Improving Sleep in a Population of Teachers
|dc.contributor.author||Price, Larry R. ( 0000-0001-6413-1286 )|
|dc.contributor.author||Kirsch, Tracey B. ( )|
|dc.contributor.author||Kuhn, John ( )|
|dc.contributor.author||Marksberry, Jeff ( )|
|dc.contributor.author||Haltiwanger, Steven G. ( )|
|dc.identifier.citation||Kirsch, T. B., Kuhn, J., Price, L. R., Marksberry, J., & Haltiwanger, S. G. (2019). A Novel Medical Device that Relieves Anxiety, Depression and Pain While Improving Sleep in a Population of Teachers. Journal of Depression and Anxiety, 8(2): 334.||en_US|
Objectives: This study was conducted to confirm the benefits of Alpha-Stim ® cranial electrotherapy stimulation (CES) technology as an effective non-drug treatment for anxiety, mood, sleep, and pain in teachers following a successful pilot study at the Leigh Academy, Dartford, United Kingdom. The second objective was to determine whether the new smartphone app was a reliable method of evaluating the effectiveness, based on the pilot study in the UK, other prior surveys, and more than 100 prospective research studies conducted on Alpha-Stim technology conducted from 1981 through 2019.
Methods: Thirty-five teachers (29 females and 6 males) in the Mineral Wells, Texas Independent School District, volunteered to participate in a study to reduce anxiety, depression, insomnia, and pain by passing a mild electric current with specific waveform characteristics through their brains via electrodes that clip on their ears. It was a six- week open-label design where participants tracked their progress using a new smartphone app to record their symptoms at least five days per week. The subjects were encouraged to use the device for 20-60 minutes any time of day and for any indication.
Results: The statistical analyses revealed highly significant (p values <0.001) for anxiety, depression, insomnia, and pain. The effect size Cohen's d values from a total of 237 treatments were greater than two standard deviations for all outcome measures indicating a high level of practical change from baseline to posttest supporting the capability of Alpha-Stim CES technology in reducing self-perceived symptoms and the ability to monitor progress on the Alpha-Stim app.
Conclusion: This treatment effect with Alpha-Stim cranial electrotherapy stimulation on anxiety, insomnia, depression, and pain was consistent with prior surveys and confirmed the precision of the new app in determining progress from a single treatment and a series of treatments.
|dc.format.medium||1 file (.pdf)|
|dc.source||Journal of Depression and Anxiety, 2019, Vol. 8, No. 2, 334|
|dc.subject||Cranial electrotherapy stimulation||en_US|
|dc.title||A Novel Medical Device that Relieves Anxiety, Depression and Pain While Improving Sleep in a Population of Teachers||en_US|
|dc.rights.license||This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|txstate.department||Counseling, Leadership, Adult Education, and School Psychology|